In this study, we revealed that miR-27a inhibits cell proliferation and invasion of cSCC, and suppresses the activation of NF-κB pathway through directly targeting EGFR, indicating that miR-27a plays a tumor suppressive role in cSCC. The gene discussed is NFKB1; the disease is neoplasm.